Abbott Laboratories (ABT)

Trade Timeline

Risk Factors

• •Medium confidence level and a Quality Score of 60/100 indicate that this is not a top-tier, low-uncertainty setup despite strong historical capture data.
• •Short-term momentum is slightly negative (5-day slope -0.0164%/day), which is mildly misaligned with the preferred positive near-term momentum for capture trades.
• •Volatility is moderate (14-day ATR 2.06%), meaning price swings around ex-date could temporarily overwhelm the $0.63 dividend and affect short-term P&L.
• •Historical stats are back-tested (sample size 172) and may not perfectly predict this specific event; a few adverse market days can materially change outcomes.
• •General market or sector shocks during the 7-day holding window can negate the statistical edge, especially in a medium-confidence, Tier 2 name.

Action Checklist

• 1.Confirm the ex-dividend date of 2026-01-15 and ensure you can enter 1 trading day prior.
• 2.Size the position based on your risk tolerance, recognizing moderate volatility (14-day ATR 2.06%) and medium confidence.
• 3.Plan entry on the day before ex-date, preferably on intraday pullbacks rather than breakouts.
• 4.Set a base exit plan for 7 trading days after ex-date consistent with the Classic Capture strategy (expected return 4.21%, historical win rate 72.1%).
• 5.Monitor price action post ex-date and consider taking profits earlier if returns approach or exceed the historical capture yield (~3.826%) or the 4.21% expectation.
• 6.Track broader market and sector news around the event window; be ready to cut the trade if a larger negative catalyst emerges.
• 7.For long-term investors, reassess ABT’s role in your portfolio as a moderate-yield, Tier 2 quality holding, and align position size with your income vs. growth objectives.